ProfileGDS5678 / 1422701_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 3% 3% 3% 34% 3% 3% 3% 4% 3% 3% 3% 3% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.002323
GSM967853U87-EV human glioblastoma xenograft - Control 21.990773
GSM967854U87-EV human glioblastoma xenograft - Control 31.979763
GSM967855U87-EV human glioblastoma xenograft - Control 42.7141234
GSM967856U87-EV human glioblastoma xenograft - Control 51.938273
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.025953
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.98873
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.9794
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.963583
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.978153
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.975433
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.965183
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.975673
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.977863